| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3291 | |||||||||||||||||||||||
| Submitter : | Mrs. Michelle Peifer | Date & Time: | 12/15/2006 08:12:38 | |||||||||||||||||||||
| Organization : | Mrs. Michelle Peifer | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I strongly disagree with the use of aborted fetal cell lines in the development of new vaccines. There are enough other options available to the pharmeceutical industry that they need not use cells from unborn children killed in abortion. Please prohibit this practice in the future for all vaccines. | ||||||||||||||||||||||||